TICAD9 side event
RBM is taking the reignition of our pursuit of Zero Malaria to the Ninth Tokyo International Conference on African Development, where we are calling for a unified Big Push against malaria through stronger south-south collaboration. At our upcoming pivotal TICAD9 side event, that we are co-hosting alongside Malaria No More US and partners, global health leaders will leverage Japan’s 30-year health collaboration with Africa to accelerate the end of malaria through innovation, investment and equity. Our diverse set of panelists will get together to celebrate progress and Japan-Africa collaboration in technology and innovation in the fight against malaria while charting the way for a unified Big Push that will enable endemic countries access the tools that they need faster.
Transformative Partnerships in Action
The panel will highlight Japan’s legacy of co-creation, from JICA’s health system strengthening to breakthrough diagnostics. Pioneering Japanese innovations now address critical gaps:
- Gene amplification technology detects low-parasite malaria (missed by 20-70% of current tests), enabling early intervention.
- AI-driven drones and rapid diagnostics deploy across 12 African nations, creating local jobs while slashing pesticide use by 70%.
Our Big Push to Zero Malaria
With malaria cases surging to 263 million in 2023, the RBM Partnership will underscore the critical need for action at the upcoming event: Japan and Africa’s trusted partnership must now fuel concrete steps—scaling diagnostics, strengthening supply chains and embedding malaria elimination within Universal Health Coverage. Zero Malaria starts when our legacy becomes action.
The Big Push priorities:
- Blended financing to accelerate locally adapted tools
- Political accountability mechanisms
- Climate-resilient innovations to combat drug-resistant strains
Pathways to Elimination
The event will mark a critical shift from aid to mutual investment, with Japan set to commit to aligning Global Fund replenishment with RBM’s country-led roadmap. Next-generation vaccines and community-driven solutions will anchor the final sprint toward 2030 goals.